Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05660018 · ClinicalTrials.gov registry record · NA
TMS Related Biomarker Assessments
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05660018 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 10 participants.
The verdict
NCT05660018, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Patients with schizophrenia spectrum disorder (SSD) will be exposed to active and sham repetitive transcranial magnetic stimulation (rTMS) in separate sessions. SSD-related biomarkers will be assessed before and after the rTMS administration.
Interventions
- DEVICE active rTMS first, then sham rTMS
- DEVICE sham rTMS first, then active rTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-01-07 |
| Est. Completion | 2025-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05660018
The ClinicalTrials.gov registry entry for NCT05660018 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which active rTMS first, then sham rTMS is the first listed.
NCT05660018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05660018 about?
NCT05660018 is a clinical study titled "TMS Related Biomarker Assessments". Patients with schizophrenia spectrum disorder (SSD) will be exposed to active and sham repetitive transcranial magnetic stimulation (rTMS) in separate sessions. SSD-related biomarkers will be assessed before and after the rTMS administration.
What is the current status of trial NCT05660018?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2023-01-07. Estimated completion is 2025-02-14.
What interventions are being tested in trial NCT05660018?
The interventions under investigation include: active rTMS first, then sham rTMS (DEVICE), sham rTMS first, then active rTMS (DEVICE).
Who is sponsoring clinical trial NCT05660018?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.